New hand-held device uses lasers, sound waves for deeper melanoma imaging

August 06, 2014

WASHINGTON, Aug. 6, 2014--A new hand-held device that uses lasers and sound waves may change the way doctors treat and diagnose melanoma, according to a team of researchers from Washington University in St. Louis. The instrument, described in a paper published today in The Optical Society's (OSA) journal Optics Letters, is the first that can be used directly on a patient and accurately measure how deep a melanoma tumor extends into the skin, providing valuable information for treatment, diagnosis or prognosis.

Melanoma is the fifth most common cancer type in the United States, and incidence rates are rising faster than those of any other cancer. It's also the deadliest form of skin cancer, causing more than 75 percent of skin-cancer deaths.

The thicker the melanoma tumor, the more likely it will spread and the deadlier it becomes, says dermatologist Lynn Cornelius, one of the study's coauthors. Being able to measure the depth of the tumor in vivo enables doctors to determine prognoses more accurately--potentially at the time of initial evaluation--and plan treatments and surgeries accordingly.

The problem is that current methods can't directly measure a patient's tumor very well. Because skin scatters light, high-resolution optical techniques don't reach deep enough. "None are really sufficient to provide the two to four millimeter penetration that's at least required for melanoma diagnosis, prognosis or surgical planning," says engineer Lihong Wang, another coauthor on the Optics Letters paper.

Researchers have tried other methods, but they aren't much better. High-frequency ultrasound doesn't have enough image contrast, and magnetic resonance imaging and positron emission tomography have insufficient resolution and require expensive and bulky instruments.

"Any type of tissue diagnosis at this point in time requires taking tissue out of the person and processing it and looking at it under the microscope," Cornelius says.

But because taking a biopsy often only involves the removal of a part of a tumor--when it's in a cosmetically sensitive area, for instance--provisional measurements of the tumor depth are not always reliable. If, at the time of excision, the surgeon finds that the tumor goes deeper than initially thought, the patient may need yet another surgery.

Recently, researchers including Wang have applied an approach called photoacoustic microscopy, which can accurately measure melanoma tumors directly on a patient's skin--thus allowing doctors to avoid uncertainty in some circumstances.

The technique relies on the photoacoustic effect, in which light is converted into vibrations. In the case of the new device, a laser beam shines into the skin at the site of a tumor. Melanin, the skin pigment that's also in tumors, absorbs the light, whose energy is transferred into high-frequency acoustic waves. Unlike light, acoustic waves don't scatter as much when traveling through skin. Tumor cells will produce more melanin than the surrounding healthy skin cells, and as a result, the acoustic waves can be used to map the entire tumor with high resolution. The device has a detector that can then turn the acoustic signal into a three-dimensional image on a screen.

Wang, Cornelius and their colleagues previously built a similar desktop device, which shines the laser directly onto the tumor. But so much light is absorbed that very little penetrates to the tumor's lower layers. The latest version, however, is not only hand-held, but it also delivers light around and below the tumor, which generates a bright image of the tumor's bottom and an accurate measurement of its depth.

The researchers tested their device on both artificial tumors made of black gelatin and on real ones in live mice, showing that the instrument could accurately measure the depths of tumors--and do it in living tissue.

Initially, this tool will be mainly used for improving how doctors plan and prepare for surgeries, Cornelius says. But what's especially exciting, she adds, is that it can measure a tumor's entire volume--something that's never been possible with melanoma. If researchers can determine how the volume relates to cancer outcomes, then this tool could give doctors a new type of measurement for diagnosis and prognosis.

The researchers are now conducting further tests with human patients. The new device will have to prove effective in clinical trials before it is widely available. But other than that Wang says, the device is essentially ready for commercialization.
-end-
Paper: "Handheld photoacoustic microscopy to detect melanoma depth in vivo," Y. Zhou et al., Optics Letters, vol. 39, issue 16, pp. 4731-4734 (2014). (http://www.opticsinfobase.org/ol/fulltext.cfm?uri=ol-39-16-4731&id=298588)

EDITOR'S NOTE: Images are available to members of the media upon request. Contact Lyndsay Meyer, lmeyer@osa.org.

About Optics Letters

Published by The Optical Society (OSA), Optics Letters offers rapid dissemination of new results in all areas of optics with short, original, peer-reviewed communications. Optics Letters covers the latest research in optical science, including optical measurements, optical components and devices, atmospheric optics, biomedical optics, Fourier optics, integrated optics, optical processing, optoelectronics, lasers, nonlinear optics, optical storage and holography, optical coherence, polarization, quantum electronics, ultrafast optical phenomena, photonic crystals, and fiber optics. This journal, edited by Xi-Cheng Zhang of the University of Rochester and published twice each month, is where readers look for the latest discoveries in optics. Visit http://www.OpticsInfoBase.org/OL.

About OSA

Founded in 1916, The Optical Society (OSA) is the leading professional society for scientists, engineers, students and business leaders who fuel discoveries, shape real-world applications and accelerate achievements in the science of light. Through world-renowned publications, meetings and membership programs, OSA provides quality research, inspired interactions and dedicated resources for its extensive global network of professionals in optics and photonics. For more information, visit http://www.osa.org.

Contact:


Lyndsay Meyer
The Optical Society
202.416.1435
lmeyer@osa.org

The Optical Society

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.